Literature DB >> 7943632

Fibronectin, laminin, type IV collagen distribution, and myofibroblastic stromal reaction in aggressive and nonaggressive basal cell carcinoma.

G De Rosa1, E Barra, M Guarino, S Staibano, V Donofrio, A Boscaino.   

Abstract

The stromal myofibroblastic reaction and extracellular matrix in a series of 19 morphologically and clinically aggressive basal cell carcinomas (BCC) were examined by an immunohistochemical staining panel for myofibroblastic markers (vimentin, actin, and desmin), for basement membrane components (laminin and type IV collagen), and for fibronectin. Results were compared with a series of 19 nonaggressive BCC. The aggressive BCC showed discontinuous staining for laminin and type IV collagen, a marked myofibroblastic response, and increased stromal fibronectin. Conversely, the nonaggressive BCC showed a continuous basement membrane and a total lack of staining for fibronectin and myofibroblastic markers in all but three cases. This report suggests that a combined analysis of extracellular matrix components and myofibroblastic markers may be useful for evaluating the clinical behavior including the metastatic capability of aggressive BCC.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7943632     DOI: 10.1097/00000372-199406000-00006

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  2 in total

1.  Expression of Snail is associated with myofibroblast phenotype development in oral squamous cell carcinoma.

Authors:  Marcus Franz; Karin Spiegel; Claudia Umbreit; Petra Richter; Carolina Codina-Canet; Angela Berndt; Annelore Altendorf-Hofmann; Sven Koscielny; Peter Hyckel; Hartwig Kosmehl; Ismo Virtanen; Alexander Berndt
Journal:  Histochem Cell Biol       Date:  2009-02-06       Impact factor: 4.304

2.  Slit2 promotes tumor growth and invasion in chemically induced skin carcinogenesis.

Authors:  Cuiling Qi; Haimei Lan; Jie Ye; Weidong Li; Ping Wei; Yang Yang; Simei Guo; Tian Lan; Jiangchao Li; Qianqian Zhang; Xiaodong He; Lijing Wang
Journal:  Lab Invest       Date:  2014-05-19       Impact factor: 5.662

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.